Singapore markets closed

Straits Times Index
3,230.55
+21.37(+0.67%)
Nikkei
26,781.68
+176.84(+0.66%)
Hang Seng
20,697.36
+581.16(+2.89%)
FTSE 100
7,585.46
+20.54(+0.27%)
BTC-USD
28,822.85
-806.41(-2.72%)
CMC Crypto 200
625.79
-3.71(-0.59%)

MAS imposes additional S$330 million capital requirement on OCBC over SMS scams

Organon & Co. (OGN)

NYSE - NYSE Delayed Price. Currency in USD

Add to watchlist

38.90

+0.34

(+0.88%)

At close: 04:04PM EDT

38.48

-0.42

(-1.08%)

After hours:

05:57PM EDT

Loading interactive chart…

Business Wire
Organon Reports Results for the First Quarter Ended March 31, 2022
JERSEY CITY, N.J., May 05, 2022--Organon (NYSE: OGN) (the "company"), today announced its results for the first quarter ended March 31, 2022.
Business Wire
Organon To Report First Quarter Results and Host Conference Call on May 5, 2022
JERSEY CITY, N.J., April 21, 2022--Organon To Report First Quarter Results and Host Conference Call on May 5, 2022
Business Wire
Organon Enters into Global License Agreement to Commercialize Daré Bioscience’s XACIATO™ (clindamycin phosphate vaginal gel, 2%), FDA-Approved Treatment for Females 12 and Older with Bacterial Vaginosis (BV)
JERSEY CITY, N.J. & SAN DIEGO, March 31, 2022--Organon Enters into Global License Agreement to commercialize Daré Bioscience’s XACIATO™ (clindamycin phosphate vaginal gel, 2%)